225 related articles for article (PubMed ID: 22018622)
21. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
Van Houtven G; Powers J; Jessup A; Yang JC
Health Econ; 2006 Aug; 15(8):775-95. PubMed ID: 16544361
[TBL] [Abstract][Full Text] [Related]
22. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
23. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care.
van den Berg B; Bleichrodt H; Eeckhoudt L
Health Econ; 2005 Apr; 14(4):363-76. PubMed ID: 15744739
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
25. Stated and actual altruistic willingness to pay for insecticide-treated nets in Nigeria: validity of open-ended and binary with follow-up questions.
Onwujekwe O; Uzochukwu B
Health Econ; 2004 May; 13(5):477-92. PubMed ID: 15127427
[TBL] [Abstract][Full Text] [Related]
26. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
Tang CH; Liu JT; Chang CW; Chang WY
Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
[TBL] [Abstract][Full Text] [Related]
27. Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness.
Haninger K; Hammitt JK
Risk Anal; 2011 Sep; 31(9):1363-80. PubMed ID: 21488924
[TBL] [Abstract][Full Text] [Related]
28. Can we estimate the 'social' value of a QALY? Four core issues to resolve.
Smith RD; Richardson J
Health Policy; 2005 Sep; 74(1):77-84. PubMed ID: 16098414
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
30. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
31. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
32. Value of a QALY and VSI estimated with the chained approach.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
[TBL] [Abstract][Full Text] [Related]
33. Estimating a constant WTP for a QALY-a mission impossible?
Sund B; Svensson M
Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
[TBL] [Abstract][Full Text] [Related]
34. Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh.
Heinzen RR; Bridges JF
Int J Technol Assess Health Care; 2008; 24(4):481-7. PubMed ID: 18828944
[TBL] [Abstract][Full Text] [Related]
35. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
36. Willingness to pay for public health services in rural Central Java, Indonesia: methodological considerations when using the contingent valuation method.
Shono A; Kondo M; Ohmae H; Okubo I
Soc Sci Med; 2014 Jun; 110():31-40. PubMed ID: 24713191
[TBL] [Abstract][Full Text] [Related]
37. Willingness to pay for potential enhancements to a low-cost cataract surgical package in rural southern China.
Ko F; Frick KD; Tzu J; He M; Congdon N
Acta Ophthalmol; 2012 Feb; 90(1):e54-60. PubMed ID: 21801337
[TBL] [Abstract][Full Text] [Related]
38. A comparison of stated preference methods for estimating monetary values.
Ryan M
Health Econ; 2004 Mar; 13(3):291-6. PubMed ID: 14981653
[TBL] [Abstract][Full Text] [Related]
39. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.
Greenberg D; Bakhai A; Neumann PJ; Cohen DJ
Health Policy; 2004 Nov; 70(2):207-16. PubMed ID: 15364150
[TBL] [Abstract][Full Text] [Related]
40. Monetary value of health-a practical decision-making framework combining equity considerations and WTP.
Ribarić E; Velić I; Bobinac A
Eur J Health Econ; 2024 May; ():. PubMed ID: 38769211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
